You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

Citation Tools

Article menu

Download PDFPDF

XML
HIV/AIDS
Protocol
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mahomed S, Garrett N, Capparelli E, et al
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
BMJ Open 2019;9:e030283. doi: 10.1136/bmjopen-2019-030283